1. 793PDPreliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations. (23rd October 2018) Authors: Abida, W; Bryce, A H; Vogelzang, N J; Amato, R J; Percent, I; Shapiro, J D; McDermott, R; Hussain, A; Patnaik, A; Petrylak, D; Ryan, C J; Stanton, T; Zhang, J; Simmons, A D; Despain, D; Collins, M; Golsorskhi, T; Scher, H I; Chowdhury, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗